← All trials
NCT02550028
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2015
- Primary completion
- Dec 1, 2019
- Completion date
- Dec 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Fudan UniversityLead sponsor
- Fudan UniversityStudy chair
- Maternal and Child Health Hospital of Hubei ProvinceCollaborator
- Guangxi Medical UniversityCollaborator
- Wenzhou Medical UniversityCollaborator
- Xiamen UniversityCollaborator
- Guangzhou Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.